Experiences with Sutent
This page shows detailed information about a medicine such as statistics, patient reviews and related articles.
Level of
Satisfaction
What patients say...
Our patients
Most common conditions
Read our patient's reviews about Sutent
16/08/2017 | | 53moderated by Susan
sunitinib malate (62,5mg) for kidney cancer
I'm a stage 4 mChRCC patient. MTOR and affinitor didn't work. At this dose, the standard schedule is 4 weeks on 2 weeks off so as not to overdose. I'm now on a schedule of 2 weeks on 1 week off. Doing this for 8 months and I'll hear in a week if this is still working and more importantly if the metastases are still increasing in volume.
> read full review...
Most reviewed medicines
The content on this page is user-generated content, read and revised before approval to comply with our standards for a medicine review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.